Status:
COMPLETED
Is Verapamil In TransRadial Interventions OmittabLe?
Lead Sponsor:
State Health Center, Hungary
Conditions:
Coronary Disease
Verapamil Toxicity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background Verapamil is traditionally applied prophylactically in transradial procedures to prevent radial artery spasm. However, verapamil may have side effects and is contraindicated in some clinica...
Eligibility Criteria
Inclusion
- patients undergoing transradial coronary angiography and/or percutaneous coronary intervention
- successful cannulation of the radial artery
Exclusion
- reduced left ventricular systolic function (LVEF\<35%)
- significant aortic stenosis
- bradycardia (\<50/min.)
- myocardial infarction complicated by cardiogenic shock and/or high grade AV block
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
591 Patients enrolled
Trial Details
Trial ID
NCT01402427
Start Date
March 1 2011
End Date
August 1 2011
Last Update
June 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State Health Center
Budapest, Hungary, 1134